Related Experiment Video

Updated: Aug 17, 2026

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture
03:42

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture

Published on: September 27, 2024

KAI1 inhibits anchorage-dependent and -independent pancreatic cancer cell growth

Xiao-Zhong Guo1, Jian-Hua Xu, Min-Pei Liu

  • 1Department of Gastroenterology, Shenyang Northern Hospital, Shenyang, China.

Oncology Reports
|June 10, 2005
PubMed

Insights

The tumor suppressor gene KAI1 inhibits pancreatic cancer cell growth and colony formation. Restoring KAI1 expression leads to cell cycle arrest, supporting its role in suppressing pancreatic cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Decreased KAI1 (CD82) tumor suppressor gene expression correlates with metastasis in pancreatic cancer.
  • Understanding KAI1's role is crucial for developing targeted pancreatic cancer therapies.

Purpose of the Study:

  • To investigate the functional impact of KAI1 on pancreatic cancer cell proliferation and colony formation.
  • To determine if KAI1 influences cell cycle progression in pancreatic cancer cells.

Main Methods:

  • Stable transfection of KAI1 cDNA into Panc-1 and MiaPaCa-2 pancreatic cancer cell lines.
  • Confirmation of transfection via Western blot and immunohistochemistry.
  • Assessment of cell growth, cell cycle distribution, and colony formation using MTT assays, flow cytometry, and colony formation assays.

Main Results:

  • KAI1 transfection resulted in cytoplasmic KAI1 immunoreactivity.
  • KAI1-expressing cells showed significantly reduced proliferation and a G0/G1 cell cycle arrest compared to control cells.
  • Colony formation was reduced by 2.6-fold in Panc-1 and 3.5-fold in MiaPaCa-2 cells transfected with KAI1.

Conclusions:

  • KAI1 effectively blocks pancreatic cancer cell growth by inducing cell cycle arrest.
  • KAI1 inhibits anchorage-independent growth, confirming its tumor suppressor function in pancreatic cancer.
  • Restoring KAI1 expression represents a potential therapeutic strategy for pancreatic cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...